Teva Settles Patent Litigation With Amicus
Sector Update: Health Care Stocks Decline Thursday Afternoon
Trump Sees Harris's Fox Interview as 'Tough but Very Fair'
Express News | Amicus Therapeutics Inc - Litigation Continues Against Aurobindo, Stay Remains for Lupin
Amicus Therapeutics Enters License Agreement With Teva, Resolving Galafold Patent Litigation; No Terms Disclosed
Express News | Amicus Therapeutics Inc - Teva to Market Generic Galafold in U.S. Starting Jan 30, 2037
Express News | Amicus Therapeutics Announces Settlement of Galafold® (Migalastat) Patent Litigation With Teva
Trump, big comeback! Is the 'Trump trade' making a comeback?
"Trump trade" is gaining momentum. The long-dormant "Trump trade" seems to be making a comeback. Among them, the stock price of the Trump Media and Technology Group has been soaring, with the stock price skyrocketing over 15.5% on October 16th Eastern Time, a cumulative increase of over 166% compared to the September low. At the same time, the "Trump trade" is boosting the prices of bitcoin and the US dollar. On the news front, there has been a major turnaround in Trump's election prospects. As of October 16th local time, a latest nationwide poll released by Fox News shows Trump leading Harris by 50% to 48%, which is different from September.
No matter who takes over the White House, financial trading activities will pick up.
Whether it's Donald Trump or Kamala Harris taking office in the White House, the market generally expects financial trading activities to heat up, bringing good news to Citigroup, Goldman Sachs, JPMorgan, and other major banks.
Express News | According to the average of the betting market provided by the website RealClearPolitics that summarizes gambling odds, as of the evening of October 16th local time, Trump's chances of winning have reached 57.7%, the highest level since July 22, far ahead
UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $26
Immuneering Rises on Orphan Drug Designation for Treatment of Pancreatic Cancer
The significant risks in November are undergoing crucial changes.
Less than a month away from the usa presidential election day on November 5th, the market is starting to price in the risks of the election results. Currently, Trump has regained a leading advantage, adding variables to the election. CICC believes that for subsequent assets, the overall bullishness of the election is favorable for US stocks but tariffs are unfavorable for chinese assets; the US dollar is relatively strong, gold is neutral, interest rates are rising; bulk commodities may benefit from expectations of Trump's stimulus.
Sector Update: Health Care Stocks Higher Friday Afternoon
Sector Update: Health Care
Harris, Trump Tied in Battle for Swing States, WSJ Poll Shows -- WSJ
teva pharmaceutical industries agreed to pay a settlement of 0.45 billion US dollars to end a US investigation into rebates.
On October 11th, the US Department of Justice announced that Israeli non-patent pharmaceutical company Teva Pharmaceutical Industries has agreed to pay a $450 million settlement to end an investigation into possible illegal kickback schemes by the company. Brian M. Boynton, Deputy Assistant Attorney General of the US Department of Justice, stated that the pharmaceutical company's practice of offering kickbacks to the industry harms fair market competition and is detrimental to the healthcare policies being implemented in the USA.
Teva Pharmaceuticals to Pay $450M to Settle Kickback Allegations
'Drug Maker Teva Pharmaceuticals Agrees to Pay $450M in False Claims Act Settlement to Resolve Kickback Allegations Relating to Copayments and Price Fixing' - DOJ
Wall Street is "waiting quietly" for the usa election, how will the election trade seize the opportunity?
The USA election is approaching, but Wall Street is surprisingly quiet.